The impact of a quality assurance process on the frequency and confirmation rate of hysterectomy
article
OA: closed
CC0
⤵ 17 in-corpus citations
AI-generated summary
This study investigated the effect of a quality assurance process on the frequency and confirmation rate of hysterectomies performed.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
A criteria-based quality assurance process for hysterectomy was instituted at a large teaching hospital. After this process was initiated, the overall frequency of hysterectomy decreased by 24%, p less than 0.001. Significant reductions were seen in hysterectomy rates for the following indications: chronic pelvic pain (77%, p less than 0.0001), recurrent uterine bleeding (46%, p less than 0.001), preinvasive disease of the uterus (55%, p less than 0.005), and severe infection (70%, p less than 0.025). Adenomyosis was the single indication for which an increase in hysterectomy rate was observed. This increase, however, was completely reversed during the last 2 years of the study. This quality assurance process also resulted in a significant increase in the histologic verification rate (i.e., 82% vs 93%, p less than 0.001). These observations suggest that using such a criteria-based process can reduce the number of hysterectomies performed and improve the accuracy of the preoperative diagnosis.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (16)
- Confirmation of the preoperative diagnoses for hysterectomy via openalex
- INDICATIONS FOR HYSTERECTOMY via openalex
- Validation of hysterectomy indications and the quality assurance process via openalex
- W1995761768 via openalex
- W2007659485 via openalex
- W2008587324 via openalex
- W2262180574 via openalex
- W2339970708 via openalex
- W2395677921 via openalex
- W2409540307 via openalex
- W2413430516 via openalex
- W4256026870 via openalex
- W6637003705 via openalex
- W6715368020 via openalex
- W1523424232 via openalex
- W1673749503 via openalex
Cited by (17)
- RETROSPECTIVE ANALYSIS OF CHANGING TRENDS IN PRESENTATION AND MANAGEMENT OF ADENOMYOSIS 2022
- Uterine Artery Embolization 2018
- Efficacy of Surgical Intervention for the Treatment of Pain and Improvement of Quality of Life in Patients with Endometriosis 2016
- Effectiveness of treatment for infertility using clinical investigation of laparoscopy cytoreductive surgery combined with gestrinone in adenomyosis 2016
- Adenomyosis at Hysterectomy: Prevalence, Patient Characteristics, Clinical Profile and Histopatholgical Findings 2012
- Future developments in the medical treatment of abnormal uterine bleeding 2011
- Adenomyosis: epidemiological factors 2006
- Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata 2005
- Laparoscopic excision of endometriosis: A randomized, placebo-controlled trial 2004
- Documenting the Current Definitions of Chronic Pelvic Pain: Implications for Research 2004
- Location of Adenomyosis in Total Hysterectomy Specimens 2003
- The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2-5 year follow-up 2003
- Evidence-Based Management of Chronic Pelvic Pain 1998
- Risk factors for adenomyosis 1997
- Evaluation of surgical options in menorrhagia 1994
- Variations in hysterectomy rates in Ontario: does the indication matter? 1994
- SURGICAL MANAGEMENT OF CHRONIC PELVIC PAIN 1993
Source provenance
- europepmc
- last seen: 2026-07-29T06:27:48.050232+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:12:05.481982+00:00
License: CC0
· commercial use OK